| name | press-release |
| description | Draft press releases for Talosix company news including feature launches, partnerships, funding, and awards following AP style and clinical trial industry conventions. |
Press Release Drafting for Talosix EDC
Purpose
Draft professional press releases that announce Talosix company news to the clinical trial industry, media, analysts, and stakeholders. All releases follow AP style, clinical trial industry conventions, and include appropriate boilerplate and media contact information.
Press Release Types
1. Product / Feature Launch
- New platform capabilities, major version releases, significant feature additions
- Focus on customer impact and clinical operations benefit
- Include customer quote if available, analyst perspective if possible
2. Partnership / Integration Announcement
- Technology partnerships, integration availability, channel partnerships
- Dual-company announcement format with quotes from both organizations
- Explain value to mutual customers
3. Funding / Financial Milestone
- Fundraising rounds, revenue milestones, profitability announcements
- Include investor quote for funding rounds
- Describe how capital will be deployed (product, team, market expansion)
4. Customer Win / Milestone
- Significant new customer (with permission), customer count milestones
- Study volume milestones, geographic expansion
- Customer quote required; anonymize if needed
5. Award / Recognition
- Industry awards, analyst recognition, certification achievements
- Reference the awarding body and selection criteria
- Connect recognition to company mission and customer outcomes
6. Leadership / Team
- Executive hires, board appointments, advisory board additions
- Include biography and relevant experience
- Quote from new hire and from existing leadership
7. Event / Conference
- Speaking engagements, conference sponsorships, hosted events
- Include session details, speaker credentials
- Provide registration or attendance information
8. Regulatory / Compliance
- New certifications (SOC 2, ISO), compliance achievements
- Validation package availability, regulatory alignment updates
- Frame in terms of customer confidence and trust
Press Release Structure (AP Style)
1. Headline
- Format: Title case, present tense, active voice
- Length: 10-15 words maximum
- Formula: [Company] + [Action Verb] + [What] + [Impact/Benefit]
- Example: "Talosix Launches AI-Powered Edit Check Engine to Reduce Clinical Data Queries by 50%"
- Do NOT use all caps, excessive punctuation, or superlatives without substantiation
2. Subheadline (Optional)
- Length: One sentence, 15-25 words
- Adds context the headline could not contain
- Example: "New capability enables real-time data quality monitoring across decentralized and traditional clinical trial sites"
3. Dateline
- Format: CITY, State (Month Day, Year) --
- Example: "SAN FRANCISCO, Feb. 24, 2026 --"
- Use AP style abbreviations for months: Jan., Feb., Aug., Sept., Oct., Nov., Dec. (March through July spelled out)
4. Lead Paragraph (Lede)
- Length: 2-3 sentences, maximum 50 words
- Answer: Who, What, When, Why, and significance
- Include the company name and the core news
- Most important information first (inverted pyramid)
5. Body Paragraphs
Paragraph 2-3: Detail and Context
- Expand on the announcement with specifics
- Product launches: key capabilities and differentiation
- Partnerships: scope and integration details
- Funding: amount, investors, use of funds
- Include relevant market context or industry trend
Paragraph 4: Quote from Talosix Executive
- CEO or relevant C-level/VP
- Should provide vision or strategic context, not repeat facts
- Format: "Quote text," said [Full Name], [Title] of Talosix. "Continuation if needed."
- Keep to 2-3 sentences
Paragraph 5: Additional Detail or Customer Impact
- Availability, pricing model (if applicable), timeline
- Customer impact statement or example
- Integration or ecosystem implications
Paragraph 6: External Quote (When Applicable)
- Customer, partner, investor, or analyst
- Provides third-party validation
- Format same as internal quote
Paragraph 7: Availability and Next Steps
- How to access the product/partnership/event
- Where to learn more
- Conference or webinar tie-in if relevant
6. Boilerplate (About Section)
About Talosix
Talosix provides modern electronic data capture (EDC) software purpose-built
for clinical trials. The Talosix platform enables sponsors, CROs, and research
sites to design, deploy, and manage clinical studies with faster build times,
higher data quality, and full regulatory compliance. Supporting studies across
all phases and therapeutic areas, Talosix is trusted by clinical teams
worldwide to accelerate the path from protocol to database lock. For more
information, visit www.talosix.com.
Update boilerplate quarterly or when company positioning evolves. Include recent metrics if available (number of studies, customers, countries).
7. Media Contact
Media Contact:
[Name]
[Title]
Talosix, Inc.
[Email]
[Phone]
8. Forward-Looking Statements (If Applicable)
Required for public companies or when making projections. Include standard safe harbor language if Talosix makes forward-looking claims.
AP Style Guidelines for Press Releases
Numbers
- Spell out one through nine; use numerals for 10 and above
- Exception: Always use numerals for percentages (5%), ages, dates, and measurements
- Use % symbol, not "percent" in press releases
Dates
- Month Day, Year format: Feb. 24, 2026
- Abbreviate months with dates except March, April, May, June, July
- Do not use ordinals (24th)
Titles
- Capitalize formal titles before names: CEO John Smith
- Lowercase titles after names: John Smith, chief executive officer
- On second reference, use last name only: Smith
Punctuation
- Use serial comma (Oxford comma) for clarity in press releases
- Em dashes with spaces: word -- word
- Single space after periods
Clinical Trial Terminology
- Capitalize proper names of regulations: 21 CFR Part 11, ICH-GCP
- Spell out acronyms on first use: electronic data capture (EDC)
- Use industry-standard terminology as defined in ICH guidelines
Tone Guidelines
- Factual and precise — State what happened, when, and why it matters
- Confident without hyperbole — "industry-leading" only if demonstrably true
- Forward-looking with caution — Express vision without making promises
- Customer-centric — Frame every announcement in terms of customer value
- Credible — Clinical trial professionals are skeptical of marketing spin
Words to Avoid
- "Revolutionary," "groundbreaking," "game-changing" (unless genuinely unprecedented)
- "Pleased to announce" (overused; just announce it)
- "Best-in-class" (unsubstantiated superlative)
- "Synergy," "leverage" (corporate jargon)
- "Excited" (acceptable once, in a quote, if truly warranted)
Preferred Phrasing
- "Designed to reduce..." not "Will revolutionize..."
- "Enables clinical teams to..." not "Is the first ever..."
- "Built for 21 CFR Part 11 compliance" not "FDA approved software"
- "Demonstrates measurable improvement" not "Unprecedented results"
Distribution Checklist
- Wire service: PR Newswire or Business Wire (for major announcements)
- Industry publications: Applied Clinical Trials, Clinical Leader, Clinical Informatics News, Outsourcing Pharma, CenterWatch
- Company channels: Website newsroom, LinkedIn company page, email to customers/partners
- Analyst relations: Direct distribution to relevant analysts (Gartner, IDC Health Insights)
- Trade associations: DIA, ACRP, SCDM newsletters or news feeds
- SEO: Publish on website newsroom with proper metadata and internal links
Embargo and Timing
- Embargo: Offer 24-48 hours to key journalists for exclusive or early coverage
- Timing: Distribute between 8:00 and 10:00 AM ET on Tuesday through Thursday
- Avoid: Major competitor announcement days, holiday weeks, major conference keynote hours (unless coordinated with event)
- Conference tie-in: Release morning of the conference day for maximum visibility
Output Deliverables
When drafting a press release, provide:
- Full press release text following the structure above
- Headline and subheadline (2 options each for selection)
- Suggested distribution list (wire + targeted outlets)
- Recommended distribution date and time
- Social media posts (LinkedIn, Twitter) to accompany the release
- Internal announcement email for employees (brief version)
